Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review

PLoS Medicine

Volumn 7, Issue 5, 2010, Pages

  Sarwar, Nadeem ^a   Aspelund, Thor ^b,c   Eiriksdottir, Gudny ^b,c   Gobin, Reeta ^a   Seshasai, Sreenivasa Rao Kondapally ^a   Forouhi, Nita G ^d   Sigurdsson, Gunnar ^b,c   Danesh, John ^a   Gudnason, Vilmundur ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ICELANDIC HEART ASSOCIATION   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

^d MRC EPIDEMIOLOGY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; BLOOD; CORONARY ARTERY DISEASE; DIET RESTRICTION; HYPERGLYCEMIA; MIDDLE AGED; REFERENCE VALUE; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS;

EID: 77953281382     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000278     Document Type: Review

References (50)

1. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, et al. (2003) Tests of glycemia in diabetes. Diabetes Care 26 (Suppl 1): S106-8.
2. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-81.
3. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-40.
4. Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164: 2147-55.
5. DECODE Study Group, the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2- hour diagnostic criteria. Arch Intern Med 161: 397-405.
6. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, et al. (2009) Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 151: 496-507.
7. Ulmer H, Kelleher C, Diem G, Concin H (2004) Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health (Larchmt) 13: 41-53.
8. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, et al. (2006) Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 29: 123-30.
9. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, et al. (2002) Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 162: 209-16.
10. Saydah SH, Miret M, Sung J, Varas C, Gause D, et al. (2001) Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24: 1397-402.
11. Cruz-Vidal M, Garcia-Palmieri MR, Costas R, Jr., Sorlie PD, Havlik RJ (1983) Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program. Diabetes Care 6: 556-61.
12. Ferrie JE, Singh-Manoux A, Kivimäki M, Mindell J, Breeze E, et al. (2009) Cardiorespiratory risk factors as predictors of 40-year mortality in women and men. Heart 95: 1250-7.
13. Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-60.
14. Scheidt-Nave C, Barrett-Connor E, Wingard DL, Cohn BA, Edelstein SL (1991) Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 133: 565-76.
15. Onat A, Hergenç G, Can G (2007) Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition. Anadolu Kardiyol Derg 7: 29-34.
16. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21: 360-7.
17. Yarnell JW, Pickering JE, Elwood PC, Baker IA, Bainton D, et al. (1994) Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 47: 383-8.
18. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, et al. (2007) The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28: 857-64.
19. Stern MP, Fatehi P, Williams K, Haffner SM (2002) Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 25: 1851-6.
20. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, et al. (2005) Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 165: 1910-6.
21. Bjornholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, et al. (1999) Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22: 45-9.
22. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, et al. (1999) Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 22: 1262-5.
23. Pyorälä M, Miettinen H, Halonen P, Laakso M, Pyorälä K (2000) Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20: 38-44.
24. Marin A, Medrano MJ, Gonzalez J, Pintado H, Compaired V, et al. (2006) Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting. BMC Public Health 6: 38.
25. Meigs JB, Nathan DM, D'Agostino RB, Sr, Wilson PW; Framingham Offspring Study. (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25: 1845-50.
26. Lawlor DA, Smith GD, Ebrahim S (2006) Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49: 41-8.
27. Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, et al. (2009) Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 17: 559-63.
28. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, et al. (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116: 151-7.
29. Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG. (2006) Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 29: 26-31.
30. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, et al. (1997) One- hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 50: 1369-76.
31. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, et al. (2004) Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141: 413-20.
32. Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G (2002) Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 9: 67-76.
33. Hoffman WS (1973) Rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem 120: 51-4.
34. Easton DF, Peto J, Babiker AG (1991) Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10: 1025-35.
35. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, et al. (1999) Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150: 341-353.
36. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-7.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-60.
38. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34.
39. WHO consultation report. Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/NCD/NCS/ 91.2.
40. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 28: 88-136.
41. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-304.
42. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M (2006) Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368: 1651-9.
43. Avendano M, Mackenbach JP (2006) Blood glucose levels: facing a global crisis. Lancet 368: 1631-2.
44. Origin Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, et al. (2008) Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 155: 26-32.
45. Holman RR (2007) A new era in the secondary prevention of CVD in prediabetes - the Acarbose Cardiovascular Evaluation (ACE) trial. Diab Vasc Dis Res 4 (Suppl 1): S40.
46. DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, et al. (2008) Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care 31: 1007-1014.
47. The NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, et al. (2010) Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. N Engl J Med 362: 1463-1476.
48. Khaw KT, Wareham N (2006) Glycated haemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol 17: 637-43.
49. Sung J, Song YM, Ebrahim S, Lawlor DA (2009) Fasting blood glucose and the risk of stroke and myocardial infarction. Circulation 119: 812-9.
50. Preiss D, Welsh P, Murray HM, Shepherd J, Packard C, et al. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J. Epub ahead of print. doi:10.1093/eurheartj/ehq095.